<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Evaluating Pharmaceutical Twitter Accounts</title>
	<atom:link href="http://prforpharma.com/2010/02/22/evaluating-pharmaceutical-twitter-accounts/feed/" rel="self" type="application/rss+xml" />
	<link>http://prforpharma.com/2010/02/22/evaluating-pharmaceutical-twitter-accounts/#utm_source=feed&#038;utm_medium=feed&#038;utm_campaign=feed</link>
	<description>Discussions about social media, PR and marketing for pharmaceutical companies</description>
	<lastBuildDate>Wed, 16 May 2012 01:30:52 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
	<item>
		<title>By: Grace Agency</title>
		<link>http://prforpharma.com/2010/02/22/evaluating-pharmaceutical-twitter-accounts/comment-page-1/#comment-734</link>
		<dc:creator>Grace Agency</dc:creator>
		<pubDate>Thu, 25 Feb 2010 15:57:39 +0000</pubDate>
		<guid isPermaLink="false">http://prforpharma.com/?p=166#comment-734</guid>
		<description>&lt;span class=&quot;topsy_trackback_comment&quot;&gt;&lt;span class=&quot;topsy_twitter_username&quot;&gt;&lt;span class=&quot;topsy_trackback_content&quot;&gt;An interesting look at pharma&#039;s foray into Twittersville. http://tinyurl.com/y8ch65s&lt;/span&gt;&lt;/span&gt;</description>
		<content:encoded><![CDATA[<p><span class="topsy_trackback_comment"><span class="topsy_twitter_username"><span class="topsy_trackback_content">An interesting look at pharma&#39;s foray into Twittersville. <a href="http://tinyurl.com/y8ch65s" rel="nofollow">http://tinyurl.com/y8ch65s</a></span></span></span></p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Chris Iafolla</title>
		<link>http://prforpharma.com/2010/02/22/evaluating-pharmaceutical-twitter-accounts/comment-page-1/#comment-735</link>
		<dc:creator>Chris Iafolla</dc:creator>
		<pubDate>Wed, 24 Feb 2010 21:37:01 +0000</pubDate>
		<guid isPermaLink="false">http://prforpharma.com/?p=166#comment-735</guid>
		<description>&lt;span class=&quot;topsy_trackback_comment&quot;&gt;&lt;span class=&quot;topsy_twitter_username&quot;&gt;&lt;span class=&quot;topsy_trackback_content&quot;&gt;Analyzing pharma&#039;s foray on to Twitter.  What can be done better?  What&#039;s done well?: http://bit.ly/cVo7sD&lt;/span&gt;&lt;/span&gt;</description>
		<content:encoded><![CDATA[<p><span class="topsy_trackback_comment"><span class="topsy_twitter_username"><span class="topsy_trackback_content">Analyzing pharma&#39;s foray on to Twitter.  What can be done better?  What&#39;s done well?: <a href="http://bit.ly/cVo7sD" rel="nofollow">http://bit.ly/cVo7sD</a></span></span></span></p>
]]></content:encoded>
	</item>
	<item>
		<title>By: uberVU - social comments</title>
		<link>http://prforpharma.com/2010/02/22/evaluating-pharmaceutical-twitter-accounts/comment-page-1/#comment-550</link>
		<dc:creator>uberVU - social comments</dc:creator>
		<pubDate>Wed, 24 Feb 2010 16:43:04 +0000</pubDate>
		<guid isPermaLink="false">http://prforpharma.com/?p=166#comment-550</guid>
		<description>&lt;strong&gt;Social comments and analytics for this post...&lt;/strong&gt;

This post was mentioned on Twitter by PRforPharma: Five lessons taught by the current state of pharma social media Twitter accounts: http://bit.ly/cVo7sD...</description>
		<content:encoded><![CDATA[<p><strong>Social comments and analytics for this post&#8230;</strong></p>
<p>This post was mentioned on Twitter by PRforPharma: Five lessons taught by the current state of pharma social media Twitter accounts: <a href="http://bit.ly/cVo7sD.." rel="nofollow">http://bit.ly/cVo7sD..</a>.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Chris Iafolla</title>
		<link>http://prforpharma.com/2010/02/22/evaluating-pharmaceutical-twitter-accounts/comment-page-1/#comment-736</link>
		<dc:creator>Chris Iafolla</dc:creator>
		<pubDate>Tue, 23 Feb 2010 20:51:02 +0000</pubDate>
		<guid isPermaLink="false">http://prforpharma.com/?p=166#comment-736</guid>
		<description>&lt;span class=&quot;topsy_trackback_comment&quot;&gt;&lt;span class=&quot;topsy_twitter_username&quot;&gt;&lt;span class=&quot;topsy_trackback_content&quot;&gt;@jonmrich Sorry, missed your Tweet yesterday re: the post you unknowingly helped on.  Here&#039;s the link: http://bit.ly/cVo7sD&lt;/span&gt;&lt;/span&gt;</description>
		<content:encoded><![CDATA[<p><span class="topsy_trackback_comment"><span class="topsy_twitter_username"><span class="topsy_trackback_content">@jonmrich Sorry, missed your Tweet yesterday re: the post you unknowingly helped on.  Here&#39;s the link: <a href="http://bit.ly/cVo7sD" rel="nofollow">http://bit.ly/cVo7sD</a></span></span></span></p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Vincent Schiavone</title>
		<link>http://prforpharma.com/2010/02/22/evaluating-pharmaceutical-twitter-accounts/comment-page-1/#comment-737</link>
		<dc:creator>Vincent Schiavone</dc:creator>
		<pubDate>Tue, 23 Feb 2010 19:15:40 +0000</pubDate>
		<guid isPermaLink="false">http://prforpharma.com/?p=166#comment-737</guid>
		<description>&lt;span class=&quot;topsy_trackback_comment&quot;&gt;&lt;span class=&quot;topsy_twitter_username&quot;&gt;&lt;span class=&quot;topsy_trackback_content&quot;&gt;Five lessons taught by the current state of pharma social media Twitter accounts: http://bit.ly/cVo7sD via RT @PRforPharma&lt;/span&gt;&lt;/span&gt;</description>
		<content:encoded><![CDATA[<p><span class="topsy_trackback_comment"><span class="topsy_twitter_username"><span class="topsy_trackback_content">Five lessons taught by the current state of pharma social media Twitter accounts: <a href="http://bit.ly/cVo7sD" rel="nofollow">http://bit.ly/cVo7sD</a> via RT @PRforPharma</span></span></span></p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Tom Peddicord</title>
		<link>http://prforpharma.com/2010/02/22/evaluating-pharmaceutical-twitter-accounts/comment-page-1/#comment-738</link>
		<dc:creator>Tom Peddicord</dc:creator>
		<pubDate>Tue, 23 Feb 2010 04:44:20 +0000</pubDate>
		<guid isPermaLink="false">http://prforpharma.com/?p=166#comment-738</guid>
		<description>&lt;span class=&quot;topsy_trackback_comment&quot;&gt;&lt;span class=&quot;topsy_twitter_username&quot;&gt;&lt;span class=&quot;topsy_trackback_content&quot;&gt;RT @PRforPharma: Five lessons taught by the current state of pharma social media Twitter accounts: http://bit.ly/cVo7sD&lt;/span&gt;&lt;/span&gt;</description>
		<content:encoded><![CDATA[<p><span class="topsy_trackback_comment"><span class="topsy_twitter_username"><span class="topsy_trackback_content">RT @PRforPharma: Five lessons taught by the current state of pharma social media Twitter accounts: <a href="http://bit.ly/cVo7sD" rel="nofollow">http://bit.ly/cVo7sD</a></span></span></span></p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Chris Iafolla</title>
		<link>http://prforpharma.com/2010/02/22/evaluating-pharmaceutical-twitter-accounts/comment-page-1/#comment-549</link>
		<dc:creator>Chris Iafolla</dc:creator>
		<pubDate>Tue, 23 Feb 2010 04:04:11 +0000</pubDate>
		<guid isPermaLink="false">http://prforpharma.com/?p=166#comment-549</guid>
		<description>Thanks for checking in Peter and for pointing me to your post.  I think your Firefly analogy is an accurate one and I do think that some sort of feeling out process needs to take place before a company can appropriately gauge what is of most interest and relevance to its core audience.</description>
		<content:encoded><![CDATA[<p>Thanks for checking in Peter and for pointing me to your post.  I think your Firefly analogy is an accurate one and I do think that some sort of feeling out process needs to take place before a company can appropriately gauge what is of most interest and relevance to its core audience.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Lodengrun14</title>
		<link>http://prforpharma.com/2010/02/22/evaluating-pharmaceutical-twitter-accounts/comment-page-1/#comment-548</link>
		<dc:creator>Lodengrun14</dc:creator>
		<pubDate>Tue, 23 Feb 2010 03:33:10 +0000</pubDate>
		<guid isPermaLink="false">http://prforpharma.com/?p=166#comment-548</guid>
		<description>Thanks for this Chris.  Very insightful about what&#039;s going on in this space.  I agree with your social media realism.  Companies need to play enough, though, to figure out how their key audiences would like to interact in social media.  I&#039;m using the term &quot;entrainment&quot; to describe this process -- &lt;a href=&quot;http://disturbingconventions.wordpress.com/2009/10/29/the-flashing-of-fireflies&quot; rel=&quot;nofollow&quot;&gt;http://disturbingconventions.wordpress.com/2009...&lt;/a&gt;&lt;br&gt;Peter</description>
		<content:encoded><![CDATA[<p>Thanks for this Chris.  Very insightful about what&#39;s going on in this space.  I agree with your social media realism.  Companies need to play enough, though, to figure out how their key audiences would like to interact in social media.  I&#39;m using the term &#8220;entrainment&#8221; to describe this process &#8212; <a href="http://disturbingconventions.wordpress.com/2009/10/29/the-flashing-of-fireflies" rel="nofollow">http://disturbingconventions.wordpress.com/2009&#8230;</a><br />Peter</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Chris Iafolla</title>
		<link>http://prforpharma.com/2010/02/22/evaluating-pharmaceutical-twitter-accounts/comment-page-1/#comment-739</link>
		<dc:creator>Chris Iafolla</dc:creator>
		<pubDate>Tue, 23 Feb 2010 02:52:52 +0000</pubDate>
		<guid isPermaLink="false">http://prforpharma.com/?p=166#comment-739</guid>
		<description>&lt;span class=&quot;topsy_trackback_comment&quot;&gt;&lt;span class=&quot;topsy_twitter_username&quot;&gt;&lt;span class=&quot;topsy_trackback_content&quot;&gt;Five lessons taught by the current state of pharma social media Twitter accounts: http://bit.ly/cVo7sD&lt;/span&gt;&lt;/span&gt;</description>
		<content:encoded><![CDATA[<p><span class="topsy_trackback_comment"><span class="topsy_twitter_username"><span class="topsy_trackback_content">Five lessons taught by the current state of pharma social media Twitter accounts: <a href="http://bit.ly/cVo7sD" rel="nofollow">http://bit.ly/cVo7sD</a></span></span></span></p>
]]></content:encoded>
	</item>
</channel>
</rss>

